A New Source of a Key Cancer Drug in Low Supply: Genetically Modified Yeast

An international team of researchers has demonstrated that engineered yeast cells can produce the crucial cancer medication vinblastine synthetically. Some cancer patients’ treatments were interrupted...

from SciTechDaily https://ift.tt/2xBA6zc